checkAd

    IN LONDON bei umgerechnet 0,81 - hier bei 0,64 !!!! - 500 Beiträge pro Seite

    eröffnet am 07.06.05 14:17:29 von
    neuester Beitrag 07.06.05 18:33:14 von
    Beiträge: 16
    ID: 985.964
    Aufrufe heute: 0
    Gesamt: 1.159
    Aktive User: 0


     Durchsuchen

    Begriffe und/oder Benutzer

     

    Top-Postings

     Ja Nein
      Avatar
      schrieb am 07.06.05 14:17:29
      Beitrag Nr. 1 ()
      Jetzt noch zuschlagen, morgen haben wir vielleicht schon den EURO hinter uns :eek:

      Hier die Wahnsinns-News von gerade :eek:

      Regulatory Announcement

      Go to market news section

      Company Crown Corporation Limited
      TIDM CCO
      Headline Preliminary Results
      Released 12:30 07-Jun-05
      Number 2426N



      RNS Number:2426N
      Crown Corporation Limited
      07 June 2005


      Crown Corporation Limited

      Preliminary Results for the period ended 31 December 2004

      Crown Corporation Limited (" Crown" or " the Company" ), the UK listed investment
      company, announces its maiden results since joining AIM in October 2003.

      Highlights for the period:

      • Pre-tax profit €243,371,000. EPS - €0.537

      • Asset value €510,000,000 equivalent to €3.53 per share (240p per share)

      Post Period Events

      • New Chief Executive appointed

      • Langbar Capital acquired for £700,000, the consideration wholly satisfied
      in Crown common shares issued at 35p each. Langbar Capital is a corporate
      finance advisory and investment company

      • Arden Partners appointed Nominated Adviser and Broker

      • Proposed reorganisation of capital structure and name change

      Stuart Pearson, Chief Executive and Acting Chairman, commented:

      " The performance of the share price has been disappointing and represents a very
      large discount to the asset value. In order to address this situation and to
      improve future returns to shareholders, the Company is pleased to announce a
      number of new initiatives, including the appointment of a new management team.

      " The strategy for the future will be to produce consistent and growing earnings
      and capital appreciation by actively managing the investments.

      " The Company is already looking at a number of interesting opportunities where
      profit and shareholder value can be significantly enhanced. Investments made are
      likely to have more of a UK focus and to be strong in assets where return on
      capital can be improved and ultimate shareholder value realised through trade
      sale or flotation."

      7 June 2005

      ENQUIRIES:

      Crown Corporation Limited Tel: 00 44 (0) 113 284 3838
      Stuart Pearson, Chief Executive

      Bankside Consultants Tel: 00 44 (0) 20 7444 4140
      Michael Padley / Susan Scott



      CHAIRMAN`S STATEMENT

      I have today been appointed Chief Executive of Crown Corporation Limited to
      replace Dr Mariusz Rybak who has stepped down to pursue other business
      interests. Dr Rybak has been chairman and chief executive of Crown since it came
      to AIM in October 2003 and I wish to place on record, our sincere thanks for his
      efforts during this period. We wish him well in his future activities.

      Also stepping down today is our non-executive director, Mr Friedrich Kramer. We
      thank him for his contribution over the last few years and wish him well in the
      future.

      The Company is now poised to make some significant changes, all aimed at
      improving the returns on our capital and to our shareholders. Before setting out
      these changes, I will quickly review the results and financial position of the
      Company.

      In November 2003, the Company obtained a number of large scale contracts in
      South America which it was able to dispose of for a significant profit. The
      gross proceeds of Euro280million (£190.4m) were satisfied by a bank guaranteed
      promissory note, maturing on 31 May 2005. I am pleased to say these Promissory
      Notes were repaid ahead of maturity and the proceeds, together with accrued
      interest, have been deposited in term deposits with the Banco do Brasil.

      The gross income for the period under review amounted to Euro285.9million
      (£194.4m) and the profit on ordinary activities was Euro243.4million (£165.5m).
      A dividend in kind has been paid of €219.5million (£149.3m) leaving
      Euro23.9million (£16.2m) to carry forward. No further dividends are proposed and
      the Company has no charge for taxation.

      During 2004 and early 2005, your Board investigated a number of major investment
      opportunities in the oil, property and mineral sectors. Unfortunately, the
      stringent criteria demanded by your Board has resulted in no projects
      progressing beyond the due diligence stage. It is now intended to broaden the
      investment criteria to include smaller capitalisation companies, joint ventures
      and pre-IPO funding. The Board also intends to provide corporate finance
      advisory services and ongoing support to its investee companies on a more
      formalised basis.

      During the year, the Company distributed to shareholders by way of a dividend in
      specie, the shares in a newly created company, Crown Pharmaceuticals Ltd (" Crown
      Pharma" ). Within Crown Pharma were Euro235.01million (£169.8m) certificates of
      bank deposits which were to be utilised to acquire a pharmaceutical business.
      This transaction did not materialise and since the year end, the certificates of
      deposits have been re-acquired by Crown in exchange for an issue of common
      shares. This transaction is a related party transaction in view of Dr Rybak`s
      interests in the share capital of Crown Pharma. The directors (other than Dr
      Rybak), who have consulted with Arden & Partners Limited, its new nominated
      adviser, consider that the terms of the transaction are fair and reasonable so
      far as the shareholders of Crown are concerned. Crown now holds over
      Euro515million (£350.2m) in term deposits awaiting investment.

      As part of the new strategy, the Board have agreed a number of new initiatives
      aimed at improving the visibility and attraction of Crown as an investment. The
      Founders Shares are to be converted to common shares on a one for one basis and
      all common shares will rank pari passu in all respects with each other.

      Crown has today agreed to acquire the whole of the issued share capital of
      Langbar Capital Limited, a corporate finance and investment company, from me and
      my family. It is intended to recommend to shareholders that the name of the
      Company be changed to Langbar International Ltd at the forthcoming Annual
      General Meeting on 25 July 2005. The Board will also be recommending the
      introduction of a share option scheme to be used as part of the long term
      incentive plans for senior executives in the Company.

      In addition the Company has appointed Arden Partners Limited as its new
      nominated adviser and broker. Crown has agreed to grant to Arden total of
      3,120,000 warrants to subscribe for new common shares of Crown at 35p each,
      exercisable for the period of two years from today. It is appropriate to thank
      Nabarro Wells for their help and support during this initial period of the
      Company`s life.

      The Board will be making further appointments in due course and it is proposed
      to establish an Advisory Board to assist the executive team in assessing its
      investment opportunities, the ongoing monitoring of investment performance and
      to provide a depth of sector experience in the proposed areas of activity.

      It is intended that the Company will be highly active and shareholders will be
      kept abreast of the expansion programme. The strong net asset position of over
      Euro3.53 per share (£2.40) and the highly motivated management team provide an
      excellent platform for sustainable long term growth.

      G Stuart Pearson
      Acting Chairman and Chief Executive 7 June 2005

      REVIEW OF BUSINESS

      During the period under review Crown investigated a number of markets in pursuit
      of its objectives of investing in under-performing companies and sectors. It
      examined a number of possible transactions in the North American market,
      particularly Canada, and various opportunities in Russia. A number of these
      appeared to be attractive but, for various reasons, none of them were completed.

      Crown was successful in acquiring substantial construction and supply contracts
      in Argentina and Brazil; however, these proved to be less attractive for the
      Group to fulfil and accordingly the Group profitably disposed of its interests
      in the contracts for US$350million.

      Crown is continuing to seek suitable investment opportunities. Various new
      initiatives have been started since the year end and further details are set out
      in the Chairman`s Statement and the Post Balance Sheet Events paragraph below.

      POST BALANCE SHEET EVENTS

      On 6 June 2005, Crown Corporation Limited acquired the whole of the issued share
      capital of Langbar Capital Limited, the consideration being satisfied by the
      issue of 2,000,000 common shares in Crown.

      On 6 June 2005, Crown Corporation Limited and CMC Crown Management Limited
      (" CMC" ) mutually agreed to terminate the existing management contract forthwith,
      and have entered into an agreement to convert the 100,000 issued Founder Shares
      into common shares, ranking pari passu with the existing common shares. The
      resolutions necessary to effect the conversion of the Founder Shares will be
      proposed at the annual general meeting of the Company to be held on 25 July
      2005. As part of the arrangements for this termination outstanding accrued
      management fees totalling Euros10,700,000 will be satisfied as to Euros5,000,000
      by the issue to CMC of new common shares of Crown at their average mid-market
      closing price over the 30 dealing days following the date of this announcement
      and as to Euros5,700,000 by the issue of loan notes redeemable on 31 May 2008
      and convertible into common shares at the same average mid-market closing price.
      It has also been agreed that payment of additional sums totalling approximately
      Euros9,500,000 due to CMC or Dr Rybak or secured by him will be deferred. The
      directors (other than Dr Rybak) who have consulted with Arden & Partners
      Limited, its new nominated adviser, consider that the terms of the transaction
      are fair and reasonable so far as the shareholders of Crown are concerned.

      PROPOSED NEW NAME

      A resolution will also be proposed at the annual general meeting on 25 July 2005
      that the name of the Company be changed to Langbar International Limited.

      PROFIT & LOSS ACCOUNT

      Note € 000s
      ------
      Revenues 285,901

      Operating expenses 3 (25,887)
      --------

      Operating result 260,014

      Finance costs - net (16,643)
      --------

      Profit on ordinary activities before taxation 243,371

      Taxation -

      Profit on ordinary activities after taxation 243,371

      Dividend in kind (219,469)
      ---------

      Profit retained (after dividend in kind) 23,902


      Profit on ordinary activities after taxation per share, basic
      and diluted 4 5.472633

      Profit retained (after dividend in kind) per share, basic and
      diluted 4 0.537479

      No separate statement of total recognised gains and losses has been presented as
      all such gains and losses have been dealt with in the profit and loss account.


      BALANCE SHEET

      Note €000s
      -------
      Hardware & Software 8
      Tangible fixed assets 8

      Investments 1,580
      Debtors 259,234
      Cash at bank and in hand 30
      ----
      Current assets 260,844


      Creditors (8,842)
      -------
      Amounts falling due within one year

      Net current assets 252,002

      Total assets 252,010

      Capital and reserves

      Called up share capital 71
      Share premium account 5 234,356
      Value adjustments through equity (6,319)
      Profit and loss account 5 23,902
      --------
      Equity shareholders` funds 252,010



      CASHFLOW STATEMENT

      Note € 000s
      ------

      Cash flow from operating activities 6 13,386

      Returns on investments and servicing finance (16,841)

      Capital expenditure and financial instruments 88
      ----

      Cash in / outflow before financing (3,367)

      Financing 3,397
      ------

      Increase in cash in the period 30


      Reconciliation of net cash flow to movement in net funds

      € 000s
      ------

      Net funds beginning of period -
      Movement during the period 30
      ----
      Net funds end of period 30



      NOTES TO THE ACCOUNTS

      1. General Information about the Company

      The Company was incorporated in Bermuda on 4 June 2003. The Company intended to
      establish itself as a diversified holding company providing management and other
      services to companies in which it would hold substantial interests.

      Crown`s primary objective is to create value for its shareholders by making
      investments in publicly traded companies in which it can assume an active role
      and have significant influence over the management and strategic direction of
      such companies.

      The Company has its registered office in Bermuda and representative office in
      Lugano in Switzerland.

      2. Accounting policies
      Accounting convention

      The attached financial statements have been prepared under the historical cost
      convention.

      Finance costs

      Finance costs of debt and non-equity shares are recognised in the profit and
      loss account over the term of such instruments at a constant rate on the
      carrying amount.

      Foreign currencies

      Assets and liabilities denominated in foreign currencies are translated at the
      rate of exchange ruling at the balance sheet date. Transactions in foreign
      currencies are recorded at the rate ruling at the date of the transaction. All
      exchange differences are taken to the profit and loss account.
      Investments

      Long term investments are described as participating interests and are
      classified as fixed assets. Short term investments are classified as current
      assets.

      Participating interests are stated at cost in the company balance sheet. Other
      investments listed on a recognised stock exchange are valued at the lower of
      cost and mid-market value at the balance sheet date. Unlisted investments are
      stated at cost. Provision is made for any impairment in the value of
      investments.

      Other financial instruments

      The other current asset financial instruments or term debt supported by such
      instruments are stated at the lower of cost and net realizable value.

      Revenues

      All net income arising from the disposal of assets held as investments is
      treated as revenues.

      3. Operating expenses From 4 June 2003
      to
      31 December 2004
      ------------------
      € 000s
      ------

      Administrative expenses (2,554)
      Depreciation of tangible fixed assets (5)
      Dividend on founders` shares (management fees) (23,328)
      --------
      (25,887)

      The founder shares are entitled to a fixed monthly dividend equal to 0.75% of
      the net assets of the Company.

      A founder share dividend of €23,327,611 for the above mentioned period, together
      with any interest thereon, has been waived by CMC, Crown Management Corporation
      Limited (CMC). CMC is the proprietor of the founder shares and is a company
      controlled by Dr. M. Rybak, a Director of the Company.


      4. Earnings per share

      Basic earnings per share have been calculated by dividing the profit on ordinary
      activities after taxation and the profit retained (after dividend in kind) for
      the period by 44,470,550 shares, being the weighted average of shares in issue
      during the period from incorporation to December 31, 2004.

      No adjustment is required to determine diluted earnings per share as the average
      market price of the common shares during the period was below the exercise price
      of the outstanding options.

      5. Profit and loss account From 4 June 2003
      to
      31 December 2004
      ------------------
      € 000s
      ------
      Profit carried forward -
      Profit for the period 243,371
      Dividend in kind: Crown Pharmaceuticals Corp (219,448)
      Dividend in kind: Crown Development (21)
      -----
      23,902


      6. Cash flow from operating activities From 4 June 2003
      to
      31 December 2004
      -----------------
      € 000s
      ------
      Reconciliation of operating loss to net cash inflow
      from operating activities
      Operating result 260,014
      Depreciation of tangible fixed assets 5
      Founder shared accrued management fee 23,328
      Increase in debtors (257,837)
      Non cash exchange loss on capital Banco
      do Brasil 2,938
      Increase prepaid expenses and accrued
      income (15,385)
      Increase in creditors 323
      -----
      13,386


      7. Dividends

      During December 2004, the Company distributed to shareholders by way of a
      dividend in specie, the shares in a newly created company, Crown Pharmaceuticals
      Ltd. Within Crown Pharmaceuticals Ltd were Euro235.01million (£169.8m)
      certificates of bank deposits which were to be utilised to acquire a
      pharmaceutical business. This transaction did not materialise and since the year
      end, the certificates of deposits have been re-acquired by Crown in exchange for
      an issue of ordinary shares of Crown. Crown now holds over Euro515million
      (£350.2m) in term deposits awaiting investment.


      8. Annual General Meeting

      The annual general meeting of the Company will be held at 12 noon on 25 July
      2005. Notice of the meeting will be circulated to shareholders with the audited
      accounts.


      Copies of the statement are available from the offices of Bankside Consultants
      Limited, 123, Cannon Street, London EC4N 5AU


      ENDS

      This information is provided by RNS
      The company news service from the London Stock Exchange
      END




      ©2004 London Stock Exchange plc. All rights reserved
      Avatar
      schrieb am 07.06.05 14:21:48
      Beitrag Nr. 2 ()
      Wir notieren immer noch ca. 20% unter dem Kurs in London. Und dort sind Umsätze ...

      :)
      Avatar
      schrieb am 07.06.05 14:23:17
      Beitrag Nr. 3 ()
      Jetzt 57 pence in London = 0,84 :eek::eek::eek:
      Avatar
      schrieb am 07.06.05 14:24:30
      Beitrag Nr. 4 ()
      Avatar
      schrieb am 07.06.05 14:24:56
      Beitrag Nr. 5 ()
      :eek:

      Trading Spotlight

      Anzeige
      InnoCan Pharma
      0,1900EUR +2,98 %
      Aktie kollabiert! Hier der potentielle Nutznießer! mehr zur Aktie »
      Avatar
      schrieb am 07.06.05 14:25:22
      Beitrag Nr. 6 ()
      Und dass scheint ihr übersehen zu haben???

      Langbar Capital acquired for £700,000, the consideration wholly satisfied in Crown common shares issued at 35p each.

      Werden nur ca. 2 Mio. neue Shares auf den Markt geworfen. Nicht schlecht!!!

      Aber kauft weiter!!:laugh:
      Avatar
      schrieb am 07.06.05 14:37:36
      Beitrag Nr. 7 ()
      +25% in frankfurt, das ding ist eine wahre rakete!:D
      Avatar
      schrieb am 07.06.05 14:40:21
      Beitrag Nr. 8 ()
      rien_ne_va_plus

      tun wir auch.....
      da merkt man das du keine ahnung hast
      Avatar
      schrieb am 07.06.05 14:42:49
      Beitrag Nr. 9 ()
      [posting]16.825.981 von wandermops am 07.06.05 14:40:21[/posting]Wovon hab ich keine Ahnung????
      Avatar
      schrieb am 07.06.05 14:56:31
      Beitrag Nr. 10 ()
      @rien_ne_va_plus

      Bei 65 Mio. Aktien sind 2 Millionen Aktien PEANUTS!!!!

      Kaufen! Marsch, Marsch....:p
      Avatar
      schrieb am 07.06.05 14:58:10
      Beitrag Nr. 11 ()
      London

      Kurs:
      14:40:39 53,39 +28,66%
      +11,89
      Taxe Stück
      Bid: 14:31:48 50,00 0
      Ask: 14:40:28 58,00 0
      Avatar
      schrieb am 07.06.05 15:17:50
      Beitrag Nr. 12 ()
      Preisdifferenz zu London 20-30 % - schon extrem der Wert. Selbst wenn die in London etwas zurückgehen, müsste bei uns noch eine Steigerung drinsein??!! Typisches Zockerpapier...das sich sogar lohnen könnte...wenn man schnell ist bei rein...und raus.

      b2
      Avatar
      schrieb am 07.06.05 15:30:59
      Beitrag Nr. 13 ()
      Vor den heute erschienene testierten Zahlen waren wir im Hoch bei 0,90 EURO.

      Jetzt da alle die Zahlen wissen werden wir diese Woche noch die 1 vor dem Komma sehen.

      Zumal die Aktie eine fairen inneren Wert von 3,53 EURO hat.

      Lets go up ...

      ;)
      Avatar
      schrieb am 07.06.05 15:44:59
      Beitrag Nr. 14 ()
      Umsätze in London zu 56 GBP :eek: - wir sind nahe Tageshoch ;)
      Avatar
      schrieb am 07.06.05 16:56:23
      Beitrag Nr. 15 ()
      [posting]16.825.981 von wandermops am 07.06.05 14:40:21[/posting]Und? Bist immer noch der gleichen Meinung???:laugh:
      Avatar
      schrieb am 07.06.05 18:33:14
      Beitrag Nr. 16 ()
      CROWN CORP COM SHS EUR0.001
      Börse: London Dom Quotes
      Datum: 07.06.05
      Tickliste Zeit Kurs Volumen
      16:51:28 52,00000 601238 = 77 Cent:)
      15:26:07 52,50000 337029
      15:18:54 52,00000 4948
      15:15:07 51,00000 10905
      15:00:52 50,00000 12500
      14:58:26 51,50000 2000
      14:40:28 54,00000 233014


      Beitrag zu dieser Diskussion schreiben


      Zu dieser Diskussion können keine Beiträge mehr verfasst werden, da der letzte Beitrag vor mehr als zwei Jahren verfasst wurde und die Diskussion daraufhin archiviert wurde.
      Bitte wenden Sie sich an feedback@wallstreet-online.de und erfragen Sie die Reaktivierung der Diskussion oder starten Sie
      hier
      eine neue Diskussion.
      IN LONDON bei umgerechnet 0,81 - hier bei 0,64 !!!!